# Umoja Biopharma

**Canonical:** https://apis.io/providers/umoja/  
**Website:** https://www.umoja-biopharma.com/  
**APIs profiled:** 0

Umoja Biopharma is a Seattle-based clinical-stage immuno-oncology company developing in vivo CAR T cell therapies for cancer. Its VivoVec lentiviral platform generates CAR T cells directly in a patient's body, removing the ex vivo manufacturing step of traditional cell therapy, and the company operates its own manufacturing facility in Louisville, Colorado. Its pipeline includes UB-VV111 (CD19), UB-VV400 (the industry's first known CD22-directed in vivo CAR T candidate, FDA IND clearance July 2026), and UB-VV500. Umoja is backed by investors including DCVC (DCVC Bio) and SoftBank Vision Fund 2. The company publishes no public developer API, OpenAPI, or developer portal; this profile captures the company identity and the security posture of its public web surface.

## Kin Score — 6.7 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 6.7).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Umoja Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Immunotherapy, Cart, Cell Therapy, Oncology, Gene Therapy, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/umoja/). Scores are computed from the provider's own public artifacts under a published rubric.